Prestige Consumer Healthcare
PBH
49.63
+0.03
+0.06%
Prestige Consumer Healthcare
US · PBH
#2733 by market cap
Listed 1970
49.63
+0.03
+0.06%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
About Prestige Consumer Healthcare
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the North American OTC Healthcare and International OTC Healthcare segments. The North American OTC Healthcare segment consists of BC and Goody's, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fleet, Gaviscon, Luden's, Monistat, Nix, Summer's Eve. The International OTC Healthcare segment includes Fess and Hydralite. The company was founded in 1996 and is headquartered in Tarrytown, NY.
- Founded
- 1996
- CEO
- Mr. Ronald M. Lombardi
- Employees
- 890
- Headquarters
- Tarrytown, New York, United States of America
- Fiscal year end
- 03-31
- Website
- prestigebrands.com
Company profile
- Exchange
- US
- Symbol
- PBH
- Market-cap rank
- #2733
- Listing date
- 1970-01-01
- Market cap
- 2.35B
- Float cap
- 2.32B
- Shares out
- 47.40M
- Float shares
- 46.72M
Sectors & themes
Drug Manufacturers - Specialty & Generic
Fractional Shares JP
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Prestige Consumer Healthcare discussion 0 comments